NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
Clinical Trials
12 trialsNCT04046250 2023-08-25
TK112690
Tosk, Inc.
Phase 2 Completed
NCT02990468 2023-03-15
BMX-HN
BioMimetix JV, LLC
Phase 1/2 Completed
NCT03101514 2021-06-23
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Phase 2 Completed
NCT02480114 2021-02-18
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Vanderbilt-Ingram Cancer Center
Phase 3 Completed
NCT02058849 2019-08-14
Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
University of Kentucky
Phase 2 Completed
NCT00615420 2019-06-05
A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer
British Columbia Cancer Agency
Phase 3 Completed
NCT02324335 2019-01-16
Brilacidin
Innovation Pharmaceuticals, Inc.
Phase 2 Completed
NCT00352118 2017-12-28
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT00101582 2016-09-27
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Swedish Orphan Biovitrum
Phase 3 Completed
NCT00698204 2014-06-05
Cox-2 Inhibition in Radiation-induced Oral Mucositis
UConn Health
Phase 2 Completed